This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kurita, A. Articles by Inoue, K. Search for Related Content PubMed PubMed Citation Articles by Kurita, A. Articles by Inoue, K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Parkinson's Disease Patient Rights Social Bookmarking                         What's this?

The Beneficial Effect of Donepezil on Visual Hallucinations in Three Patients with Parkinson's Disease

Department of Neurology, Jikei University School of Medicine, Tokyo, Japan, a-kurita{at}jikei.ac.jp.

Yusuke Ochiai, MD

Department of Psychiatry, Jikei University School of Medicine, Tokyo, Japan

Yu Kono, MD

Department of Neurology, Jikei University School of Medicine, Tokyo, Japan

Masahiko Suzuki, MD, PhD

Department of Neurology, Jikei University School of Medicine, Tokyo, Japan

Kiyoharu Inoue, MD, PhD

Department of Neurology, Jikei University School of Medicine, Tokyo, Japan

Visual hallucinations (VHs) are common psychiatric symptoms in patients with long-standing Parkinson's disease (PD). Treatment with neuroleptics or withdrawal of anti-PD drugs may improve VHs but will worsen motor dysfunctions. The authors report on 3 patients with long-standing PD who were treated with the cholinesterase inhibitor donepezil for the treatment of VHs. Each received a daily dose of 5 mg of donepezil, after reducing or discontinuing anti-PD medications had failed to relieve the VHs. In 2 patients (patient 1, 2), donepezil decreased VHs without worsening motor dysfunctions. In addition, the cognitive status of patient 2 improved. In patient 3, donepezil also resolved VHs, but delusions developed during treatment. After discontinuing donepezil, delusions disappeared and VHs reappeared. Donepezil may ameliorate visual hallucinations in PD patients, but controlled, double-blind trials are necessary to further clarify the effect of this drug on VHs in PD. (J Geriatr Psychiatry Neurol 2003; 16:184-188).

Key Words: Parkinson's disease • acetylcholinesterese inhibitor • donepezil • visual hallucinations • cognitive impairment • motor functions

Journal of Geriatric Psychiatry and Neurology, Vol. 16, No. 3, 184-188 (2003)
DOI: 10.1177/0891988703256054


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Samuel, I. Maidment, M. Boustani, and C. Fox Clinical management of Parkinson's disease dementia: pitfalls and progress Adv. Psychiatr. Treat., March 1, 2006; 12(2): 121 - 129. [Abstract] [Full Text] [PDF]

				T. Chow Rivastigmine modestly improves dementia associated with Parkinson's disease, but has important adverse effects Evid. Based Ment. Health, May 1, 2005; 8(2): 41 - 41. [Full Text] [PDF]

				D. P. Wint, M. S. Okun, and H. H. Fernandez Psychosis in Parkinson's Disease J Geriatr Psychiatry Neurol, September 1, 2004; 17(3): 127 - 136. [Abstract] [PDF]

				D. Aarsland, U. P. Mosimann, and I. G. McKeith Role of Cholinesterase Inhibitors in Parkinson's Disease and dementia with Lewy Bodies J Geriatr Psychiatry Neurol, September 1, 2004; 17(3): 164 - 171. [Abstract] [PDF]